Cargando…

Exhaled volatile organic compounds discriminate patients with chronic obstructive pulmonary disease from healthy subjects

Chronic obstructive pulmonary disease (COPD) is a chronic airway inflammatory disease characterized by incompletely reversible airway obstruction. This clinically heterogeneous group of patients is characterized by different phenotypes. Spirometry and clinical parameters, such as severity of dyspnea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Besa, Vasiliki, Teschler, Helmut, Kurth, Isabella, Khan, Amir Maqbul, Zarogoulidis, Paul, Baumbach, Joerg Ingo, Sommerwerck, Urte, Freitag, Lutz, Darwiche, Kaid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346009/ https://www.ncbi.nlm.nih.gov/pubmed/25759572 http://dx.doi.org/10.2147/COPD.S76212

Ejemplares similares

Learning from the Cardiologists and Developing Eluting Stents Targeting the Mtor Pathway for Pulmonary Application; A Future Concept for Tracheal Stenosis
por: Zarogoulidis, Paul, et al.
Publicado: (2013)

Association of time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected bacteria of patients after solid organ transplantation
por: Schmalz, Gerhard, et al.
Publicado: (2018)

Pulmonale Manifestation hämatoonkologischer Erkrankungen und Therapien
por: Palmowski, Karin, et al.
Publicado: (2015)

Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today
por: Kallianos, Anastasios, et al.
Publicado: (2013)

“One-stop shop” spectral imaging for rapid on-site diagnosis of lung cancer: a future concept in nano-oncology
por: Darwiche, Kaid, et al.
Publicado: (2013)

Molecular Targeted Drugs and Biomarkers in NSCLC, the Evolving Role of Individualized Therapy
por: Domvri, Kalliopi, et al.
Publicado: (2013)

Transtracheal single-point stent fixation in posttracheotomy tracheomalacia under cone-beam computer tomography guidance by transmural suturing with the Berci needle – a perspective on a new tool to avoid stent migration of Dumon stents
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2015)

DDMC-p53 gene therapy with or without cisplatin and microwave ablation
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2015)

EGFR-TKIs in adjuvant treatment of lung cancer: to give or not to give?
por: Milovancev, Aleksandar, et al.
Publicado: (2015)

The role of second-line chemotherapy in small cell lung cancer: a retrospective analysis
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013)

Cone Beam Computertomography (CBCT) in Interventional Chest Medicine - High Feasibility for Endobronchial Realtime Navigation
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2014)

Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?
por: Zarogoulidis, Paul, et al.
Publicado: (2017)

Radiation Exposure of Patients by Cone Beam CT during Endobronchial Navigation - A Phantom Study
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2014)

Defining the Role of Tyrosine Kinase Inhibitors in Early Stage Non-Small Cell Lung Cancer
por: Lampaki, Sofia, et al.
Publicado: (2015)

Exhaled volatile organic compounds for diagnosis of hepatocellular carcinoma
por: Sukaram, Thanikan, et al.
Publicado: (2022)

Exhaled volatile organic compounds for diagnosis and monitoring of asthma
por: Savito, Luisa, et al.
Publicado: (2023)

“Denervation” of autonomous nervous system in idiopathic pulmonary arterial hypertension by low-dose radiation: a case report with an unexpected outcome
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2014)

Oral health-related quality of life of patients after solid organ transplantation is not affected by oral conditions: results of a multicentre cross-sectional study
por: Schmalz, Gerhard, et al.
Publicado: (2021)

Target Analysis of Volatile Organic Compounds in Exhaled Breath for Lung Cancer Discrimination from Other Pulmonary Diseases and Healthy Persons
por: Koureas, Michalis, et al.
Publicado: (2020)

Exhaled Breath Analysis for Lung Cancer Detection Using Ion Mobility Spectrometry
por: Handa, Hiroshi, et al.
Publicado: (2014)

New dilemmas in small-cell lung cancer TNM clinical staging
por: Zarogoulidis, Konstantinos, et al.
Publicado: (2013)

Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath
por: Chen, Xing, et al.
Publicado: (2017)

Chemoresistive Sensors for Cellular Type Discrimination Based on Their Exhalations
por: Astolfi, Michele, et al.
Publicado: (2022)

Standardised exhaled breath collection for the measurement of exhaled volatile organic compounds by proton transfer reaction mass spectrometry
por: Bikov, Andras, et al.
Publicado: (2013)

Could Somatostatin Enhance the Outcomes of Chemotherapeutic Treatment in SCLC?
por: Domvri, Kalliopi, et al.
Publicado: (2015)

Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2013)

Clinical analysis on diagnostic accuracy of Bosch Vivalytic SARS-CoV-2 point-of-care test and evaluation of cycle threshold at admission for COVID-19 risk assessment
por: Heger, Lukas Andreas, et al.
Publicado: (2022)

Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer
por: Oguma, Tsuyoshi, et al.
Publicado: (2017)

Exhaled Volatile Organic Compounds for Identifying Patients With Chronic Pulmonary Aspergillosis
por: Li, Zheng-Tu, et al.
Publicado: (2021)

Volatile Markers for Cancer in Exhaled Breath—Could They Be the Signature of the Gut Microbiota?
por: Bhandari, Manohar Prasad, et al.
Publicado: (2023)

Validating Discriminative Signatures for Obstructive Sleep Apnea in Exhaled Breath
por: Streckenbach, Bettina, et al.
Publicado: (2022)

Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer
por: Boutsikou, Eftimia, et al.
Publicado: (2013)

Exhaled volatile organic compounds associated with risk factors for obstructive pulmonary diseases: a systematic review
por: Shahbazi Khamas, Shahriyar, et al.
Publicado: (2023)

Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia
por: Schnabel, Ronny, et al.
Publicado: (2015)

Evaluation of Bio-VOC Sampler for Analysis of Volatile Organic Compounds in Exhaled Breath
por: Kwak, Jae, et al.
Publicado: (2014)

Limited clinical value of exhaled volatile organic compound measurements in childhood asthma
por: Fuglsbjerg, Maria G., et al.
Publicado: (2018)

Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease
por: Obermeier, Juliane, et al.
Publicado: (2017)

Volatile Organic Compounds in Exhaled Breath as Fingerprints of Lung Cancer, Asthma and COPD
por: Ratiu, Ileana Andreea, et al.
Publicado: (2020)

Non-volatile organic compounds in exhaled breath particles correspond to active tuberculosis
por: Chen, Dapeng, et al.
Publicado: (2022)

Relationship between lung function and exhaled volatile organic compounds in healthy infants
por: Sola‐Martínez, Rosa A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4vb7sr4f2h33arvlrlhgdud6ur